Multiple Manufacturers

TRUVADA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Truvada HCPCS:

J0750

HCPCS Code Descriptor:

Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)

Category:

J Code

Truvada NDCs:

69238-2095-03, 70710-1367-03, 82009-0109-30, 61958-0701-01, 65862-0354-30, 64380-0719-04, 60505-4202-03, 42543-0719-04, 42385-0953-30, 42291-0439-30, 33342-0106-07, 00378-1930-93, 31722-0560-30, 16714-0534-01, 00904-7172-07, 00093-7704-56

Primary Type:

Anti-HIV

Generic/Specialty Status:

Multi-Source

Package Type:

Not Found

Route of Administration:

Oral

Truvada CPT Codes:

Potential CPT administration codes for Truvada can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

60505-4202-03

About Truvada:

TRUVADA is a medication manufactured by multiple manufacturers and aligned to the J Code: J0750. TRUVADA is administered via the oral route of administration.

Truvada is a drug used for prevention of infection for HIV. It is prescribed to those who are currently HIV negative, but pose high risks for infection. Truvada is a combination of two different medications: emtricitabine and tenofovir disoproxil fumarate.

ACCESS PRICING AND MORE BY REGISTERING

J0750 Added Date:

January 2, 2024

J0750 Effective Date:

January 2, 2024

J0750 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Truvada billing and coding information.
Our team did not identify a source for Truvada patient assistance information. Please reach out to our team if you feel that this is a mistake.
TRUVADA prescribing information can be found at the link below:
Information regarding TRUVADA’s side effects can be found at MedlinePlus